Tara Culp-Pressler
ThinkProgress
On Thursday more than 100 prominent oncologists came out in support of a patient-driven initiative to lower the high price of cancer drugs, charging at least 20 percent of their patients can’t follow their cancer treatment because they can’t afford the drugs. In their article in Mayo Clinic Proceedings the physicians also called upon the federal government to, among other things, allow Medicare to negotiate directly with pharmaceutical companies to lower drug prices.
Spread the word